Rezolute RZLT
NASDAQ RZLT
$4.57 +0.03 (+0.77%)
As of: Sep 4, 2026 · 1:38 PM EDT

Rezolute (RZLT) Income towards Parent Company (2012 - 2026)

Rezolute (RZLT) posted Income towards Parent Company of -$20.9 million for Q1 2026, up 17.2% sequentially from -$25.3 million in Q4 2025, and up 13.68% YoY from -$18.4 million in Q1 2025.

Analysis

Rezolute (RZLT) Income towards Parent Company (2012 - 2026) Analysis & Trends

Rezolute has reported Income towards Parent Company for 15 years, with the latest figure at -$20.9 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 13.68% year-over-year to -$20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.3 million (down 43.66% YoY) and the FY2025 annual result came in at -$164.3 million, down 105.04% from the prior year.
  • Income towards Parent Company climbed to -$20.9 million in Q1 2026 per RZLT's latest filing, from -$25.3 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$10.0 million in Q3 2022 and troughed at -$92.5 million in Q3 2025.
  • A 5-year average of -$23.7 million and a median of -$19.8 million in 2024 frame the typical range for Income towards Parent Company.
  • The widest YoY moves for Income towards Parent Company: up 27.66% in 2025, down 158.47% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$14.1 million in 2022, then fell by 0.68% to -$14.2 million in 2023, then tumbled by 145.39% to -$34.9 million in 2024, then climbed by 27.66% to -$25.3 million in 2025, then increased by 17.2% to -$20.9 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$20.9 million, -$25.3 million, and -$92.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn -
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn
10 Rezolute 475.98 Mn 475.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -16.17 Mn
Dec 31, 2025 -22.77 Mn
Sep 30, 2025 -18.14 Mn
Jun 30, 2025 -24.41 Mn
Mar 31, 2025 -18.91 Mn
Dec 31, 2024 -15.74 Mn
Sep 30, 2024 -15.36 Mn
Jun 30, 2024 -22.06 Mn
Mar 31, 2024 -15.09 Mn
Dec 31, 2023 -13.89 Mn
Sep 30, 2023 -14.51 Mn
Jun 30, 2023 -12.76 Mn
Mar 31, 2023 -15.66 Mn
Dec 31, 2022 -13.54 Mn
Sep 30, 2022 -9.82 Mn
Jun 30, 2022 -11.78 Mn
Mar 31, 2022 -11.20 Mn
Dec 31, 2021 -12.59 Mn
Sep 30, 2021 -8.08 Mn
Jun 30, 2021 -7.07 Mn